Jab that protects against multiple variants 'at least two years away'

  • 📰 YahooSG
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 71%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

There were “core scientific challenges” to developing a vaccine that could protect against many mutations of the virus.

Scientists hope to create a"100-day" vaccine - Alexandru Pavalache/EyeEmthat provides broad protection against many different Covid variants is at least two years away, a vaccine expert has warned.

He said studies showed that people who were infected with Sars, a closely related virus that caused an epidemic in 2003 to 2004, also produced antibodies to Covid By contrast, the first Covid vaccine was developed in 11 months - while this was an “unprecedented” acceleration of the normal vaccine development timeline it “wasn’t good enough”, said Dr Hatchett.

But he said that as well as vaccine development it was also important to fund infrastructure such as manufacturing facilities and logistics.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-flu joint booster jab possible late 2023: ModernaGENEVA: Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said on Monday (Jan 17), hoping a joint jab would encourage people to get an annual shot. The single vaccine for COVID-19, influenza and respiratory syncytial virus - a common virus that cause
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

‘Nocebo effect’: two-thirds of Covid jab reactions not caused by vaccine, study suggestsUS researchers show negative version of placebo effect behind many symptoms such as headaches and fatigue
Source: YahooSG - 🏆 3. / 71 Read more »

Valneva says early studies show COVID-19 vaccine effective against OmicronFrench biotech firm Valneva said on Wednesday (Jan 19) that preliminary studies showed that three doses of its inactivated COVID-19 vaccine candidate neutralised the Omicron variant of the disease. All of the serum samples tested presented neutralizing antibodies against the ancestral virus and Delta varia
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Biden hails 'enormous progress' in first year despite COVID-19 pandemicWASHINGTON: A defiant President Joe Biden acknowledged missteps over the still-raging pandemic on Wednesday (Jan 19) but hailed a year of \u0022enormous progress\u0022 on the US economy as he took stock of his first year in office. In a rare news conference marking his first 12 months, Biden touted a perio
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Man on mask mission, neighbour with kampung spirit: New book showcases unsung Covid-19 heroes
Source: straits_times - 🏆 5. / 69 Read more »

Austrian COVID-19 cases shatter record as Omicron spreadsVIENNA: Austria\u0027s new daily coronavirus infections on Wednesday (Jan 19) shattered the previous record as the highly contagious Omicron variant continued to spread, government data showed. Austria is bracing for a further surge in cases, in line with what has happened in other European countries. Austria e
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »